Christoph U Correll
Charite University, Berlin, Germany · Northwell Health · North Shore LIJ
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christoph U Correll as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:29 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06759402 · Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)Charite University, Berlin, Germany · recruiting · Anorexia Nervosa, Anorexia in Adolescence · principal investigator
- N/ANCT05480046 · Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a RelapseRovi Pharmaceuticals Laboratories · completed · Schizophrenia · study chair
- N/ANCT04404309 · Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)Charite University, Berlin, Germany · unknown · Depression, Depression Moderate, Depression Severe · principal investigator
- N/ANCT04383470 · Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 PandemicUniversity of Padova · unknown · Mental Health Wellness 1, Pandemic · principal investigator
- Ph4NCT02357797 · Adjunctive Vortioxetine in SchizophreniaNorthwell Health · unknown · Schizophrenia, Negative Symptoms · principal investigator
- Ph4NCT02357849 · Fluoxetine vs Aripiprazole Comparative Trial (FACT)Northwell Health · terminated · Attenuated Psychosis Syndrome · principal investigator
- N/ANCT00169988 · Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative SymptomsNorthwell Health · completed · Prodromal Schizophrenia, Psychotic Disorders · study director
- Ph4NCT00048828 · Treating Drug-Resistant Childhood SchizophreniaNorthwell Health · completed · Schizophrenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Treating Refractory Childhood SchizophreniaR01MH060229 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · fiscal years 2005 · $329,722 awarded in 2005Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:29 UTC. The ranking covers the 200 most relevant of 112 PubMed records, and a shared surname and initials can bring in a namesake. All 112 on PubMed
- Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.Am J Psychiatry · 2016613 citationsRCR 31.5
- Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters.Am J Psychiatry · 2015222 citationsRCR 10.4
- 202 citationsRCR 38.0
- Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.JAMA Psychiatry · 2017188 citationsRCR 8.2
- Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.J Clin Psychiatry · 2007176 citationsRCR 5.6
- Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial.JAMA Psychiatry · 2020159 citationsRCR 12.2
- Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.Biol Psychiatry · 2008157 citationsRCR 5.3
- Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.Am J Psychiatry · 2015144 citationsRCR 6.6
- 130 citationsRCR 5.1
- The RAISE early treatment program for first-episode psychosis: background, rationale, and study design.J Clin Psychiatry · 2015125 citationsRCR 6.4